⌛ Did you miss ProPicks’ 13% gains in May? Subscribe now & catch June’s top AI-picked stocks early.Unlock Stocks

U.S. physical therapy COO Eric Williams sells $260,550 in stock

Published 05/14/2024, 06:22 PM
USPH
-

Eric Williams, the Co-Chief Operations Officer of U.S. Physical Therapy Inc. (NYSE:USPH), has sold a portion of his stock in the company. On May 10, 2024, Williams sold 2,500 shares of common stock at an average price of $104.22 per share, totaling $260,550. The shares were sold in multiple transactions with prices ranging from $104.00 to $105.00.

Following the sale, Williams still holds a significant stake in the company, with 16,814 shares remaining in his possession. The transactions were disclosed in a regulatory filing with the Securities and Exchange Commission.

Investors often monitor insider sales as they can provide insights into an executive’s perspective on the company's current valuation and future prospects. However, it is also common for executives to sell shares for personal financial planning or diversification reasons.

U.S. Physical Therapy Inc., based in Houston, Texas, operates clinics across the United States that provide outpatient physical therapy services. The company has been expanding its reach and services, aiming to capitalize on the growing demand for physical therapy driven by an aging population and increased health awareness.

As of now, U.S. Physical Therapy has not issued any official statement regarding the transaction, and it remains a routine disclosure as part of the company's financial transparency. Investors and analysts will continue to observe the company's performance and any future transactions by its executives.

InvestingPro Insights

Amid the news of Eric Williams' recent stock sale, investors in U.S. Physical Therapy Inc. (NYSE:USPH) can gain additional insights by considering some key financial metrics and expert analysis provided by InvestingPro. The company currently holds a market capitalization of approximately $1.6 billion and is trading at a high earnings multiple with a P/E ratio of 87.92, which adjusts to 65.32 for the last twelve months as of Q1 2024. Despite this high valuation, USPH's revenue has shown healthy growth of 7.35% over the last twelve months as of Q1 2024.

One of the InvestingPro Tips highlights that USPH has raised its dividend for three consecutive years and has maintained dividend payments for 14 consecutive years. This consistent dividend payout is complemented by a current dividend yield of 1.65%. Furthermore, the company's liquid assets exceed short-term obligations, indicating a solid liquidity position. This financial stability is further underscored by a moderate level of debt, as noted in another InvestingPro Tip.

For investors looking to delve deeper into the financial health and forecasts for USPH, InvestingPro offers additional tips. There are 11 more tips available, including insights on net income growth, analyst earnings revisions, and the company's profitability track record. To explore these insights and enhance your investment strategy, consider using InvestingPro and get an additional 10% off a yearly or biyearly Pro and Pro+ subscription with the coupon code PRONEWS24.

As the company navigates the evolving healthcare landscape, these financial metrics and expert tips from InvestingPro can serve as valuable tools for investors assessing the implications of insider transactions and the overall investment potential of U.S. Physical Therapy Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.